China Immunotech (Beijing) Biotechnology Co LTD

Two Chinese biotechs developing recombinant herpes zoster vaccines have garnered support from venture capital and private equity firms by raising a combined more than CNY700m ($104m) over the past few

Shanghai-based Abbisko Therapeutics Co., Ltd. and Sichuan Huiyu Pharmaceutical Co., Ltd. have become the latest Chinese biopharmaceutical companies to go public, maintaining the strong fundraising m

The world of cell, gene and RNA therapy, which at one time may have seemed like a thing of fiction, is not only reality, but a reality that is growing at speed. With nearly 3,500 therapies in preclini